These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32689880)

  • 1. Neuroinflammation after SCI: Current Insights and Therapeutic Potential of Intravenous Immunoglobulin.
    Gillespie ER; Ruitenberg MJ
    J Neurotrauma; 2022 Feb; 39(3-4):320-332. PubMed ID: 32689880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed administration of high dose human immunoglobulin G enhances recovery after traumatic cervical spinal cord injury by modulation of neuroinflammation and protection of the blood spinal cord barrier.
    Chio JCT; Wang J; Surendran V; Li L; Zavvarian MM; Pieczonka K; Fehlings MG
    Neurobiol Dis; 2021 Jan; 148():105187. PubMed ID: 33249350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury.
    Fehlings MG; Nguyen DH
    J Clin Immunol; 2010 May; 30 Suppl 1(Suppl 1):S109-12. PubMed ID: 20437085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of spinal cord injury with intravenous immunoglobulin G: preliminary evidence and future perspectives.
    Tzekou A; Fehlings MG
    J Clin Immunol; 2014 Jul; 34 Suppl 1(Suppl 1):S132-8. PubMed ID: 24722853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of human immunoglobulin G on enhancing tissue protection and neurobehavioral recovery after traumatic cervical spinal cord injury are mediated through the neurovascular unit.
    Chio JCT; Wang J; Badner A; Hong J; Surendran V; Fehlings MG
    J Neuroinflammation; 2019 Jul; 16(1):141. PubMed ID: 31288834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimmunological therapies for treating spinal cord injury: Evidence and future perspectives.
    Chio JCT; Xu KJ; Popovich P; David S; Fehlings MG
    Exp Neurol; 2021 Jul; 341():113704. PubMed ID: 33745920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury.
    Nguyen DH; Cho N; Satkunendrarajah K; Austin JW; Wang J; Fehlings MG
    J Neuroinflammation; 2012 Sep; 9():224. PubMed ID: 22998664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmful and beneficial effects of inflammation after spinal cord injury: potential therapeutic implications.
    David S; López-Vales R; Wee Yong V
    Handb Clin Neurol; 2012; 109():485-502. PubMed ID: 23098732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Intravenous Delivery of Human Brain Stromal Cells Modulates Systemic Inflammation and Leads to Vasoprotection in Traumatic Spinal Cord Injury.
    Badner A; Vawda R; Laliberte A; Hong J; Mikhail M; Jose A; Dragas R; Fehlings M
    Stem Cells Transl Med; 2016 Aug; 5(8):991-1003. PubMed ID: 27245367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maresin 1 Promotes Inflammatory Resolution, Neuroprotection, and Functional Neurological Recovery After Spinal Cord Injury.
    Francos-Quijorna I; Santos-Nogueira E; Gronert K; Sullivan AB; Kopp MA; Brommer B; David S; Schwab JM; López-Vales R
    J Neurosci; 2017 Nov; 37(48):11731-11743. PubMed ID: 29109234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor rehabilitation as a therapeutic tool for spinal cord injury: New perspectives in immunomodulation.
    Walsh CM; Gull K; Dooley D
    Cytokine Growth Factor Rev; 2023 Feb; 69():80-89. PubMed ID: 36114092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute spinal cord injury: A review of pathophysiology and potential of non-steroidal anti-inflammatory drugs for pharmacological intervention.
    Hayta E; Elden H
    J Chem Neuroanat; 2018 Jan; 87():25-31. PubMed ID: 28803968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury.
    Thom V; Arumugam TV; Magnus T; Gelderblom M
    Front Immunol; 2017; 8():875. PubMed ID: 28824617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation: A Target for Treatment in Spinal Cord Injury.
    Freyermuth-Trujillo X; Segura-Uribe JJ; Salgado-Ceballos H; Orozco-Barrios CE; Coyoy-Salgado A
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy strategies for spinal cord injury.
    Wang YT; Lu XM; Chen KT; Shu YH; Qiu CH
    Curr Pharm Biotechnol; 2015; 16(6):492-505. PubMed ID: 25860061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomaterial-supported MSC transplantation enhances cell-cell communication for spinal cord injury.
    Lv B; Zhang X; Yuan J; Chen Y; Ding H; Cao X; Huang A
    Stem Cell Res Ther; 2021 Jan; 12(1):36. PubMed ID: 33413653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of timing in the treatment of spinal cord injury.
    Saghazadeh A; Rezaei N
    Biomed Pharmacother; 2017 Aug; 92():128-139. PubMed ID: 28535416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation.
    Jordan SC; Toyoda M; Vo AA
    Expert Rev Clin Immunol; 2011 May; 7(3):341-8. PubMed ID: 21595600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-energy extracorporeal shock wave therapy promotes vascular endothelial growth factor expression and improves locomotor recovery after spinal cord injury.
    Yamaya S; Ozawa H; Kanno H; Kishimoto KN; Sekiguchi A; Tateda S; Yahata K; Ito K; Shimokawa H; Itoi E
    J Neurosurg; 2014 Dec; 121(6):1514-25. PubMed ID: 25280090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation by intravenous immunoglobulin: role of regulatory T cells.
    Maddur MS; Othy S; Hegde P; Vani J; Lacroix-Desmazes S; Bayry J; Kaveri SV
    J Clin Immunol; 2010 May; 30 Suppl 1():S4-8. PubMed ID: 20405183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.